No Data
No Data
Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update
MONTREAL, June 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmaceutical company focused on the development and commercialization of
Theratechnologies Inc. (TSE:TH) Has Found A Path To Profitability
Theratechnologies Up Near 5% In US After Hours On Data Related To Its Lead Investigational Peptide Drug Conjugate Candidate
Theratechnologies Inc. (TSX: TH and NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, was at last look up near 5% in US after hours T
Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients With Solid Tumors
Poster highlights durable disease stabilization lasting beyond treatment completionResults suggest a unique, multimodal mechanism of action that differs from other cancer therapeuticsFavorable tolerability sets stage for
Theratechnologies (THTX) Gets a Buy From JonesTrading
Theratechnologies Shareholders Elect Directors, Appoint Auditors